NMRA Financials

Neumora Therapeutics, Inc. - Financial statements & key metrics

Stock Price

$1.33

Market Cap

$283.48M

P/E Ratio

-0.9

EPS

$-1.47

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-243.79M

EPS (Diluted)

$-1.53

Balance Sheet Highlights

Total Assets

$316.97M

Total Liabilities

$29.91M

Shareholders Equity

Cash & Equivalents

$142.15M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-182.94M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-104.4%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is NMRA revenue?

View NMRA's income statement for detailed revenue data.

Is NMRA profitable?

NMRA reported a loss of $243.79M in the most recent quarter.

What is NMRA market cap?

NMRA has a market capitalization of $283.48M, making it a small-cap stock.

Does NMRA have debt?

View NMRA's balance sheet for debt information.

What is NMRA cash flow?

Cash flow data is available in the full financial statements.